FY26-pharmacy adempas
Ended Awarded Last action
- Contract number
- 15B50926F00000078
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
Federal Correctional Institution Fort Worth
Correctional Facilities, Department of Justice
- Obligated
- $24,792
Award facts
- Contract value 100% obligated
- $24,792.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
About this award
Bayer Healthcare Pharmaceuticals Inc. received a $24,792.22 firm fixed-price delivery order from the Federal Correctional Institution Fort Worth on April 1, 2026, for the supply of Adempas (riociguat), a medication used to treat pulmonary arterial hypertension. The delivery order, which carries an ultimate completion date of May 31, 2026, was issued without a small business set-aside designation, consistent with Bayer's classification as a large, foreign-owned pharmaceutical enterprise. The place of performance is located in Whippany, New Jersey, where Bayer Healthcare Pharmaceuticals Inc. maintains its principal operations.
This delivery order was issued under Bayer Healthcare Pharmaceuticals Inc.'s $840 million multiple-award Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the Department of Veterans Affairs, which enables federal agencies across civilian and military sectors to procure a comprehensive range of pharmaceutical products at pre-negotiated pricing. The award also aligns with a specialized $6.8 million Blanket Purchase Agreement established between Bayer and the VA National Acquisition Center in October 2025, specifically designated for Xofigo and Adempas procurement through October 5, 2026. This contract vehicle streamlines federal access to critical specialty medications by eliminating the need for additional competitive solicitations on individual task orders.
Quick answers
Who was awarded contract 15B50926F00000078?
15B50926F00000078 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Federal Correctional Institution Fort Worth (Correctional Facilities) on April 1, 2026.
How much is contract 15B50926F00000078 worth?
The government has obligated $24,792 on 15B50926F00000078.
Is contract 15B50926F00000078 an order under another contract?
Yes. 15B50926F00000078 is a delivery order under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50926F00000078 competed?
The extent of competition for 15B50926F00000078 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award